These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9717867)

  • 1. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder.
    van Balkom AJ; de Haan E; van Oppen P; Spinhoven P; Hoogduin KA; van Dyck R
    J Nerv Ment Dis; 1998 Aug; 186(8):492-9. PubMed ID: 9717867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.
    van Oppen P; van Balkom AJ; de Haan E; van Dyck R
    J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.
    Neziroglu F; Yaryura-Tobias JA; Walz J; McKay D
    J Child Adolesc Psychopharmacol; 2000; 10(4):295-306. PubMed ID: 11191690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder.
    van Oppen P; de Haan E; van Balkom AJ; Spinhoven P; Hoogduin K; van Dyck R
    Behav Res Ther; 1995 May; 33(4):379-90. PubMed ID: 7755525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
    Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
    Cavedini P; Erzegovesi S; Ronchi P; Bellodi L
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):45-9. PubMed ID: 9088884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder.
    Herbst N; Voderholzer U; Thiel N; Schaub R; Knaevelsrud C; Stracke S; Hertenstein E; Nissen C; Külz AK
    Psychother Psychosom; 2014; 83(3):165-75. PubMed ID: 24732962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental obsessive-compulsive disorder as a prognostic factor in a year long fluvoxamine treatment in childhood and adolescent obsessive-compulsive disorder.
    Yaryura-Tobias JA; Grunes MS; Walz J; Neziroglu F
    Int Clin Psychopharmacol; 2000 May; 15(3):163-8. PubMed ID: 10870874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive and compulsive symptoms.
    Reznik I; Sirota P
    Clin Neuropharmacol; 2000; 23(3):157-60. PubMed ID: 10895399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.
    Ghaleiha A; Entezari N; Modabbernia A; Najand B; Askari N; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S
    J Psychiatr Res; 2013 Feb; 47(2):175-80. PubMed ID: 23063327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
    Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
    J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: one-year followup.
    Cottraux J; Mollard E; Bouvard M; Marks I
    Psychiatry Res; 1993 Oct; 49(1):63-75. PubMed ID: 8140182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.
    Arabzadeh S; Shahhossenie M; Mesgarpour B; Rezaei F; Shalbafan MR; Ghiasi Z; Akhondzadeh S
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28485008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Effects of a Herbal Drug based on
    Noras MR; Soltanifar A; Salari R; Jarahi L; Abrishami MH
    Curr Drug Discov Technol; 2022; 19(5):e240622206368. PubMed ID: 35748547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.